Sabzevari Helen sold 119,250 shares of PRECIGEN, INC. at $4.36 for −$520k on May 28, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
President and CEO
President and CEO
Filed Jun 1, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$519,930Shares × reported price
Shares traded
119,250Common Stock
Price per share
$4.36Reported price. Read footnotes for ranges.
% of reported position traded
3.07%This security and ownership context
Holdings after
3,768,872Direct
Trade date
May 28, 2026Sell
Filed
Jun 1, 2026, 4:25 PM ET4-day reporting delay
Accession
0000950103-26-008168Code S · Transaction 388100
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 3,888,122 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

PGEN price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
PGEN · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −2.4%1w ago +3.9%1d ago +6.8%
Returns since7d −13%30d +27%90d +69%180d1y

Footnotes in full

F1: Represents the number of shares of Precigen common stock sold pursuant to a sell-to-cover transaction to satisfy tax withholding obligations upon the vesting of restricted stock units on May 23, 2026.